Products for Research Use Only
RegisterLogin

Tovetumab

CAT: 0804-HY-P99223-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99223-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC) [1][2].
CAS Number
1243266-04-7
Product Name Alternative
MEDI-575
UNSPSC
12352203
Target
PDGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tovetumab.html
Purity
99.49
Solubility
10 mM in DMSO
Smiles
[Tovetumab]
Molecular Weight
(145.39 kDa)
References & Citations
[1]Meina Liang, et al. A Novel Pharmacodynamic Biomarker and Mechanistic Modeling Facilitate the Development of Tovetumab, a Monoclonal Antibody Directed Against Platelet-Derived Growth Factor Receptor Alpha, for Cancer Therapy. AAPS J. 2020 Nov 18;23 (1) :4. |[2]Naomi Laing, et al. Inhibition of platelet-derived growth factor receptor α by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer. Mol Pharmacol. 2013 Jun;83 (6) :1247-56.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Isoform
PDGFRα

Alternative Products

CatalogName
T76764-01Tovetumab
GTR18338021-01Tovetumab Antibody
KPTX194Tovetumab ELISA Kit
MBS1563568-01Research Grade Tovetumab
E55B0393Tovetumab (Reference antibody)
ICH5100-10mgTovetumab Biosimilar - Research Grade
048258PDGFRA/CD140a (Tovetumab) discontinued
ABS-227-1mgTovetumab Biosimilar, Research Grade
GTR18697829-01Tovetumab Human Monoclonal Antibody
GTR18780823-01(Tovetumab) Biosimilar Reference Antibody

Popular Products